comparemela.com

Latest Breaking News On - Andreas jungfer - Page 1 : comparemela.com

HepaRegeniX reports positive topline results of its Phase 1 Clinical Trial of HRX-0215, a First-In-Class MKK4 inhibitor

12.05.2022 HepaRegeniX reports positive topline results of its Phase 1 Clinical Trial of HRX-0215, a First-In-Class MKK4 inhibitor | HRX | Liver | Liverregeneration | MKK4 |

United kingdomKatja arnoldAndreas jungferShaun brownWolfgang albrechtMc servicesHeparegenix gmbhMitogen activated proteinManaging director

MIG Capital continues to grow after excellent financial year 2021

27.04.2022 MIG Capital continues to grow after excellent financial year 2021 | Biontech | Creative Balloons | Hemovent

Michael motschmannAndreas jungferRaimund gabrielGerman federal financial supervisory authority bafinMc servicesGerman federal ministry of educationBavarian academy of sciencesInternational media inquiriesLeibniz computing centerZadient technologiesCreative balloonsMimi hearingMicroport surgicalGeneral partnerOmx therapeuticsFrontier biotech

APEIRON shareholders approve new group structure geared towards enabling innovation and growth

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Ios gmbPeter llewellyn daviesAndreas jungferLaurie doyleRaimund gabrielPharma ltdMc servicesIos holdingTherapies gmbhEnhancement platformInvestor relationsCovid 19Globe newswire

HepaRegeniX Appoints Elias Papatheodorou as New Chairman of the Board of Directors

HepaRegeniX Appoints Elias Papatheodorou as New Chairman of the Board of Directors
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

United statesBaden wübergUnited kingdomElias papatheodorouKatja arnoldLars zenderAndreas jungferShaun brownGraham dixonWolfgang albrechtAscenion gmbMc servicesUniversity hospital tubingenBoehringer ingelheim venture fundCornell universityIthaca college

HepaRegeniX GmbH: HepaRegeniX Appoints Elias Papatheodorou as New Chairman of the Board of Directors

TUBINGEN, GERMANY / ACCESSWIRE / March 30, 2022 / HepaRegeniX GmbH, a clinical stage company developing novel regenerative therapy approaches for the treatment of acute and chronic liver diseases, announced

United statesBaden wübergUnited kingdomElias papatheodorouKatja arnoldLars zenderAndreas jungferShaun brownGraham dixonWolfgang albrechtKostenloser wertpapierhandelAscenion gmbMc servicesUniversity hospital tubingenBoehringer ingelheim venture fundCornell university

vimarsana © 2020. All Rights Reserved.